Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Olema Pharmaceuticals Inc (OLMA)

Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Olema Oncology Presents Compelling New Preclinical Data Demonstrating Anti-Tumor Activity for OP-3136 with Enhanced Activity of Palazestrant Combinations at ENA 2024

OLMA : 12.15 (+4.56%)
Olema Oncology Announces New Preclinical Combination Data to be Presented at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

OLMA : 12.15 (+4.56%)
Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032

/CNW/ -- According to a "highly troubling" new study, the rising number of cancer cases in young people is being attributed to "accelerated aging." Further...

ONCY : 1.1650 (-1.27%)
CELC : 15.20 (+1.81%)
OLMA : 12.15 (+4.56%)
BIO : 368.05 (-0.10%)
AZN : 71.40 (-0.03%)
ONC.TO : 1.62 (-2.41%)
Biotech's Developments in Race Against Rising Cancer Rates Revealed

USA News Group – According to a “highly troubling” new study, the rising number of cancer cases in young people is being attributed to “accelerated aging.” Further alarm is being spread by the...

ONCY : 1.1650 (-1.27%)
ONC.TO : 1.62 (-2.41%)
CELC : 15.20 (+1.81%)
OLMA : 12.15 (+4.56%)
BIO : 368.05 (-0.10%)
AZN : 71.40 (-0.03%)
Stocks Fall as Bond Yields Climb on Strong US Economic News

The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.51%. Stock indexes this...

$SPX : 5,723.68 (-0.09%)
SPY : 570.39 (-0.11%)
$DOWI : 41,841.36 (-0.50%)
DIA : 418.37 (-0.49%)
$IUXX : 20,026.55 (-0.03%)
QQQ : 487.04 (-0.08%)
^BTCUSD : 67,780.84 (-2.07%)
ZNZ24 : 110-135 (+0.36%)
HUM : 255.30 (-2.08%)
CVS : 55.07 (-1.33%)
UNH : 558.37 (-1.62%)
CNC : 64.19 (+1.05%)
Stocks Retreat as Bond Yields Jump on Diminished Fed Rate Cut Prospects

The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.47%. Stock indexes this...

$SPX : 5,723.68 (-0.09%)
SPY : 570.39 (-0.11%)
$DOWI : 41,841.36 (-0.50%)
DIA : 418.37 (-0.49%)
$IUXX : 20,026.55 (-0.03%)
QQQ : 487.04 (-0.08%)
ZNZ24 : 110-135 (+0.36%)
HUM : 255.30 (-2.08%)
CVS : 55.07 (-1.33%)
UNH : 558.37 (-1.62%)
ELV : 417.63 (+0.87%)
CNC : 64.19 (+1.05%)
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer

USA News Group – More people are getting breast cancer this year. Around 300,000 women and 2,800 men will find out they have it. While 1 out of every 8 women will hear they have breast cancer sometime...

ONCY : 1.1650 (-1.27%)
ONC.TO : 1.62 (-2.41%)
PFE : 27.83 (-0.93%)
ARVN : 27.12 (+0.82%)
OLMA : 12.15 (+4.56%)
AZN : 71.40 (-0.03%)
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer

USA News Group – More people are getting breast cancer this year. Around 300,000 women and 2,800 men will find out they have it. While 1 out of every 8 women will hear they have breast cancer sometime...

AVRN : 0.0125 (-30.56%)
ONCY : 1.1650 (-1.27%)
ONC.TO : 1.62 (-2.41%)
PFE : 27.83 (-0.93%)
ARVN : 27.12 (+0.82%)
OLMA : 12.15 (+4.56%)
AZN : 71.40 (-0.03%)
Olema Oncology Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Received Fast Track designation from U.S. FDA for OP-1250 for the treatment of ER+/HER2- metastatic breast cancerReported progress across OP-1250 clinical...

OLMA : 12.15 (+4.56%)
Olema Oncology Advances OP-1250 into Phase 2 Monotherapy Expansion in Patients with ER+/HER2- Advanced Breast Cancer

SAN FRANCISCO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), today announced the advancement...

OLMA : 12.15 (+4.56%)

Barchart Exclusives

Square Looks Cheap Ahead of Earnings, But is the Stock a Buy?
Down almost 75% from all-time highs, Block is a fintech stock that trades at an attractive multiple, making it an enticing investment option at current valuations. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar